G

    GLPG (GLPG)

    Official site

    BIOTECHNOLOGY

    $27.73
    -1.08 (-3.75%)

    Last updated: May 07, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    74%(29/39)
    Avg Surprise
    +110.49%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Jun 30, 2026
    EPS Consensus$-6.24
    Range$-11.71 - $-0.77
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate Drift
    90d ago$0.28+104.5%
    60d ago$0.28+104.5%
    30d ago$-0.57+90.8%
    7d ago$-0.57+90.8%
    Current$-6.24
    Revenue Consensus
    $33M
    Range$12M - $75M
    3 analysts
    Period ending Sep 30, 2026
    EPS Consensus$-0.77
    Range$-0.87 - $-0.66
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate Drift
    90d ago$0.41+152.9%
    60d ago$0.41+152.9%
    30d ago$-0.56+26.8%
    7d ago$-0.56+26.8%
    Current$-0.77
    Revenue Consensus
    $33M
    Range$11M - $75M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$4.88---
    Sep 26EST
    		-$-0.77---
    Jun 26EST
    		-$-6.24---
    Mar 26
    Reported May 6
    		$0.25N/A+119.69%Beat+110.1%
    Dec 25
    Reported Feb 23
    		$16.38$1.00+1538.00%Beat+4078.6%
    Sep 25
    Reported Nov 5
    		$-3.59$-0.20-1696.36%Miss-366.6%
    Jun 25
    Reported Jul 23
    		$-1.89$-0.67-182.27%Miss-1450.9%
    Mar 25
    Reported Apr 23
    		$-2.47$-0.23-973.91%Miss-733.3%
    Dec 24
    Reported Feb 28
    		$0.39$-0.24+263.33%Beat-83.6%
    Sep 24
    Reported Oct 30
    		$-0.77$-0.27-185.19%Miss-297.4%
    Jun 24
    Reported Sep 12
    		$0.14$0.03+450.10%Beat+75.0%
    Mar 24
    Reported May 2
    		$0.39$-0.12+425.00%Beat+1.2%
    Dec 23
    Reported Feb 23
    		$2.39$-1.18+302.54%Beat+175.6%
    Sep 23
    Reported Nov 3
    		$0.39$-0.62+162.90%Beat+18.2%
    Jun 23
    Reported Aug 3
    		$0.08N/A+111.43%Beat+127.6%
    Mar 23
    Reported May 4
    		$0.39N/A+144.28%Beat+292.6%
    Dec 22
    Reported Feb 23
    		$-3.16$-0.64-393.75%Miss-1364.0%
    Sep 22
    Reported Nov 3
    		$0.33N/A+131.43%Beat+133.3%
    Jun 22
    Reported Aug 4
    		$-0.29N/A+56.06%Beat+70.4%
    Mar 22
    Reported May 5
    		$-0.20N/A+74.03%Beat-242.9%
    Dec 21
    Reported Feb 24
    		$0.25N/A+122.32%Beat+128.4%
    Sep 21
    Reported Nov 4
    		$-0.99$-1.38+28.26%Beat+20.8%
    Jun 21
    Reported Aug 5
    		$-0.98$-1.27+22.83%Beat+44.6%
    Mar 21
    Reported May 6
    		$0.14N/A+112.73%Beat+117.9%
    Dec 20
    Reported Feb 18
    		$-0.88$-1.20+26.67%Beat+58.1%
    Sep 20
    Reported Nov 5
    		$-1.25$-1.06-17.92%Miss-120.7%
    Jun 20
    Reported Aug 6
    		$-1.77$-0.92-92.39%Miss-105.8%
    Mar 20
    Reported May 6
    		$-0.78$-0.65-20.00%Miss+12.4%
    Dec 19
    Reported Feb 20
    		$-2.10$-0.12-1650.00%Miss-877.8%
    Sep 19
    Reported Oct 24
    		$6.03$4.24+42.22%Beat+2053.6%
    Jun 19
    Reported Jul 25
    		$-0.86$-0.77-11.69%Miss-104.8%
    Mar 19
    Reported Apr 25
    		$-0.89$-0.99+10.10%Beat-21.9%
    Dec 18
    Reported Feb 21
    		$0.27N/A+142.86%Beat+145.8%
    Sep 18
    Reported Oct 24
    		$0.28N/A+129.17%Beat+138.9%
    Jun 18
    Reported Aug 2
    		$-0.42N/A+51.16%Beat+43.2%
    Mar 18
    Reported Apr 25
    		$-0.73$-0.90+18.89%Beat-151.7%
    Dec 17
    Reported Feb 23
    		$-0.59$-0.63+6.35%Beat-158.4%
    Sep 17
    Reported Oct 30
    		$-0.72$-1.01+28.71%Beat-38.5%
    Jun 17
    Reported Jul 28
    		$-0.74$-0.74+0.00%Beat-
    Mar 17
    Reported Apr 27
    		$-0.29$-0.56+48.21%Beat-
    Dec 16
    Reported Feb 24
    		$1.01$0.02+4950.00%Beat-
    Sep 16
    Reported Oct 27
    		$-0.52$-0.60+13.33%Beat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$28.26
    SMA 20$28.59
    SMA 50$30.32
    SMA 200$32.15
    EMA 10$28.34
    EMA 20$28.69
    EMA 50$29.94
    EMA 200$31.00

    MACD

    Line: -0.56Signal: -0.65Hist: 0.08

    ADX

    ADX: 24.4+DI: 15.9-DI: 37.9

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$28.97

    Bollinger Bands

    Upper Band$29.53
    Lower Band$27.64
    %B Position660%(Upper)
    Band Width0.05

    RSI (14-Day)

    Neutral
    36.5

    Momentum Oscillators

    Stoch %K46.3
    Stoch %D47.2
    Williams %R-74.9
    ROC (10d)-3.3%
    Momentum-0.95
    CCI (20d)-140.1
    MFI (14d)38.9

    Volatility Measures

    ATR (14d)$0.72(2.6%)
    StdDev (20d)0.47
    Hist Vol21.2%(Moderate)

    Volume Flow

    VWAP$27.81
    OBV5.1M
    AD Line288.1K
    CMF (20d)-0.102

    Volume Metrics

    Avg Vol (20d)144.8K
    Vol Ratio2.0x(High)
    VWMA (20d)$28.47

    Pivot Points

    R3$29.34
    R2$29.16
    R1$28.98
    Pivot Point$28.80
    S1$28.62
    S2$28.44
    S3$28.26

    Advanced Oscillators

    TSI-23.65
    Ultimate Osc46.5
    KST-63.02

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$6.48M$900.82M$71.16M$65.29M$74.98M$75.50M$59.85M$77.87M$62.43M$-209,124,000$120.03M$149.95M
    Cost of Revenue$4.80M$455,000$10.85M$4.71M$13.73M$112.93M$19,000$16.56M$2.55M$84.43M$5.70M$4.27M
    Gross Profit$1.68M$900.37M$60.31M$60.58M$61.25M$-37,433,000$59.83M$61.32M$59.88M$-209,124,000$114.33M$145.69M
    Operating Expenses$65.39M$141.57M$306.74M$117.61M$219.96M$25.29M$114.14M$99.50M$93.02M$-139,815,000$144.56M$156.38M
    R&D$30.96M$107.51M$73.88M$95.28M$182.75M$573.73M$93.05M$73.61M$71.61M$-70,886,000$100.31M$108.35M
    SG&A$35.51M$2.94M$34.55M$18.80M$43.80M$41.25M$46.58M$15.83M$30.79M$-87,917,000$84.66M$39.41M
    Operating Income$-63,703,000$758.80M$-246,425,000$-57,027,000$-158,708,000$-62,721,000$-54,305,000$-38,181,000$-33,131,000$-69,309,000$-30,233,000$-10,690,000
    Interest Income$0$0$0$9.95M$12.56M$18.71M$23.13M$23.71M$25.71M$27.69M$21.71M$20.05M
    Interest Expense$139,252$970,719$23.52M$661,936$780,000$97,000$275,000$285,000$254,000$0$286,101$782,000
    Income Before Tax$13.96M$783.15M$-221,493,000$-104,424,000$-156,367,000$19.03M$-49,141,000$4.09M$22.93M$-62,023,000$25.73M$18.46M
    Income Tax Expense$70,000$666,000$-17,499,000$26,000$-1,814,000$-93,000$-571,000$-571,000$-568,000$-3,897,000$-100,000$13.36M
    Net Income$14.49M$782.15M$-202,111,000$-105,748,000$-153,403,000$25.31M$-50,430,000$8.98M$90.22M$157.56M$25.83M$5.10M
    EBITDA$-63,703,000$560.50M$-189,533,000$-101,118,000$-158,708,000$-53,871,000$-152,761,000$78.43M$23.19M$-65,020,000$29.82M$35.53M
    EBIT$-63,703,000$560.50M$-197,977,000$-101,118,000$-158,708,000$-62,721,000$-152,761,000$60.27M$23.19M$-65,020,000$29.82M$16.96M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about GLPG

    News

    Acquisition of Own Shares

    Lakefront Biotherapeutics announced the repurchase of 77,667 of its own shares between June 15 and June 19, 2026, as part of a previously announced repurchase program. The total value of these repurchases amounted to over €1.9 million at an average price of €24.6586 per share. As of June 19, 2026, the company holds 116,204 of its own ordinary shares.

    GlobeNewswire•6/23/26•
    Somewhat-Bullish

    Galapagos appoints Aaron Cox as CFO

    Galapagos has announced the appointment of Aaron Cox as its new Chief Financial Officer. This strategic hire aims to strengthen the company's financial leadership.

    MSN•6/19/26•
    Somewhat-Bullish

    Galapagos NV (GLPG) Earnings Forecast: Future EPS & Revenue Growth Estimates

    The article provides an earnings forecast for Galapagos NV (GLPG), indicating a current earnings forecast score of 4.67 and ranking 345 out of 385 in its industry. Analysts have a "Sell" rating for the stock, with an average target price of $28.00. The company's expected revenue for the next quarter is $9.21 million, and the previous quarter's EPS was $13.94, with an expectation of $-5.36 for the next quarter.

    TradingKey•6/18/26•
    Neutral

    Galapagos NV (GLPG) Shareholder Structure: Major Shareholders & Institutional Holdings

    This article provides a detailed breakdown of Galapagos NV's (GLPG) shareholder structure, including major individual and institutional holdings. It lists the top five shareholders by proportion, such as Gilead Sciences, Inc. and Tang Capital Management, LLC, and categorizes shareholders by type. The report also includes historical institutional shareholding data and recent shareholder activity with changes in holdings.

    TradingKey•6/17/26•
    Neutral

    Frequently Asked Questions About GLPG

    Does GLPG pay dividends?
    GLPG (GLPG) does not currently pay a regular dividend.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In